Relief Therapeutics share temporarily + 40%: Study with Aviptadil against Covid-19 started 04/07/20
The biotechnology company Relief Therapeutics has started a study with the drug Aviptadil in Miami under the supervision of the American health agency FDA. This is to be tested for its suitability for the treatment of Covid-19 and the associated breathing difficulties (ARDS), as the company announced on Tuesday. The study is being led by … Read more